Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Psychoeducation in families of children with attention deficit hyperactivity disorder (ADHD) in Spain
ISRCTN ISRCTN32884424
ClinicalTrials.gov identifier
Public title Psychoeducation in families of children with attention deficit hyperactivity disorder (ADHD) in Spain
Scientific title Psychoeducation in families of children with attention deficit hyperactivity disorder (ADHD) in Spain: evaluation of the efficacy in a randomised controlled trial
Acronym N/A
Serial number at source N/A
Study hypothesis 1. Psychoeducation intervention in families of attention deficit hyperactivity disorder (ADHD) children/adolescents will lead to a significant reduction of ADHD symptoms in these children in comparison with a control group
2. Psychoeducation intervention in families of ADHD children/adolescents will lead to improvement of treatment adherence rates in these children in comparison with a control group
3. Psychoeducation intervention in families of ADHD children/adolescents will lead to improvement of quality of life in these families in comparison with a control group
Lay summary
Ethics approval Local medical ethics committee (Complejo Hospitalario de Jaen, Spain) approved in September 2007
Study design Single centre randomised controlled double-blind parallel group trial
Countries of recruitment Spain
Disease/condition/study domain Attention deficit disorder (ADD)/attention deficit hyperactivity disorder (ADHD)
Participants - inclusion criteria 1. Diagnosis of attention deficit disorder (ADD)/ADHD in child (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition [DSM-IV]), with most of their co-morbidity represented (except for the exclusion criteria), and any treatment prescribed
2. Age of child between 3 and 19 years, either sex
3. Informed consent of the parents and the children available
4. Parents' age greater than or equal to 18 years
5. Responsibility and legal capacity in parents
6. Participant on clinical ADHD symptoms stabilisation for at least 1 month before entering the study (with or without medical treatment)
Participants - exclusion criteria 1. Severe Autistic Spectrum Disorders (*)
2. Severe learning disabilities (*)
3. Earlier or current participation in other intervention trials that might interfere with the current study

(*) due to added problems to ADHD, thus requiring a different sort of intervention
Anticipated start date 01/09/2009
Anticipated end date 01/09/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 70 (35 intervention group, 35 control group)
Interventions Psychoeducation intervention (experimental group):
Families of ADHD children/adolescents attending psychoeducation sessions. Psychoeducation provided by Child and Adolescent Psychiatrist and consisting of 12 weekly sessions, 90 minutes length, groups of 8 - 10 families.

Sessions organisation:
1. 10 - 20 minutes: "warm-up" period, informal conversation, doubts from the previous session
2. 30 - 35 minutes: lecture on the topic
3. 10 minutes: brief pause
4. 30 - 40 minutes: topic discussion
Participants encouraged to ask and make comments.

Psychoeducation program for ADHD:
Session 1: Presentations and group functioning rules. What is ADHD?
Session 2: Core symptoms. Diagnostic procedures
Session 3: Etiological, maintaining and perpetuating factors
Session 4: Comorbidities in ADHD
Session 5: Prognosis and outcome: ADHD in the adolescent and the adult
Session 6: Executive function
Session 7: Pharmacological treatments: stimulants and non-stimulants
Session 8: Diets and other treatments
Session 9: Cognitive behavioural treatment and other management approaches
Session 10: Dealing with everyday-life problems at home I
Session 11: Dealing with everyday-life problems at home II
Session 12: Dealing with everyday-life problems at school
Session 13: Summarising, final questions and doubts. Closing down session.

Support group (active control group):
Families of ADHD children/adolescents. Parents attending 12 weekly sessions, 90 minutes length, groups of 8 - 10 families, non-structured support groups provided by the same Child and Adolescent Psychiatrist. Control group only differs on the educational content provided.
Primary outcome measure(s) ADHD-symptoms by Conners Scale, measured at baseline, 12 weeks, 6 months, 9 months, and 15 months
Secondary outcome measure(s) 1. Attitudes Towards Treatment Questionnaire (QATT)
2. Adherence levels measured by direct questioning to families and pill counting (integrated into a composite)
3. Psychiatric conditions: Strengths and Difficulties Questionnaire (SDQ)
4. Children's Global Assessment Scale (C-GAS)
5. Clinical Global Impression (CGI)
6. Quality of life by PedsQL™ Core Version 4 and Cognitive Scale
7. Satisfaction with psychoeducation program by the Consumer Satisfaction Questionnaire
8. Parents Stress Index (PSI), 3th Edition

Assessments on all measures pre-treatment and post-treatment. Follow-up assessment on all measures after 3 months, 6 months and 12 months.
Sources of funding 1. The Alicia Koplowitz Foundation (Fundacion Alicia Koplowitz) (Spain)
2. Carlos III Institute of Health (Instituto de Salud Carlos III) (Spain) (ref: ETS 07/90902)
Trial website
Publications
Contact name Dr  Maite  Ferrin
  Address Fundacion para la Investigacion Biosanitaria de Andalucia Oriental (FIBAO)
Dr Azpitarte 4, Edificio Licinio de la Fuente, 4ª planta
  City/town Granada
  Zip/Postcode 18014
  Country Spain
  Tel +34 958 02 02 45
  Fax +34 958 02 01 83
  Email maiteferrin@yahoo.es
Sponsor Fundacion para la Investigacion Biosanitaria de Andalucia Oriental (FIBAO) (Spain)
  Address Dr Azpitarte 4, edificio Licinio de la Fuente, 4ª planta
  City/town Granada
  Zip/Postcode 18014
  Country Spain
  Tel +34 958 02 02 45
  Fax +34 958 02 01 83
  Email pilar.martinez.exts@juntadeandalucia.es
  Sponsor website: http://www.fibao.es/
Date applied 30/01/2010
Last edited 24/02/2010
Date ISRCTN assigned 24/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central